Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03338842 · ClinicalTrials.gov registry record · NA

Virtual Reality Treatment for Phantom Limb Pain

A NA study of Phantom Limb Pain and Lower Limb Amputation Below Knee (Injury), sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT03338842 is a NA study of Phantom Limb Pain and Lower Limb Amputation Below Knee (Injury) that has completed, run by University of Pennsylvania. The registered enrollment target is 14 participants, below the 121-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03338842, a NA study of Phantom Limb Pain and Lower Limb Amputation Below Knee (Injury), has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

Patients with limb amputations experience the sensation of the missing extremity, which is sometimes coupled with a persistent and debilitating pain in the missing limb, a condition known as phantom limb pain (PLP). This study will test the use of virtual reality (VR) training as a possible treatment of PLP.

Interventions

  • DEVICE Distractor and Lower limb VR

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-01-12
Est. Completion 2019-11-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03338842

The ClinicalTrials.gov registry entry for NCT03338842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 121-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (88% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Phantom Limb Pain appearing as the primary indexed condition, and to 1 intervention - of which Distractor and Lower limb VR is the first listed.

NCT03338842 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03338842 about?

NCT03338842 is a clinical study titled "Virtual Reality Treatment for Phantom Limb Pain". Patients with limb amputations experience the sensation of the missing extremity, which is sometimes coupled with a persistent and debilitating pain in the missing limb, a condition known as phantom limb pain (PLP). This study will test the use of virtual reality (VR) training as a possible treatmen...

What is the current status of trial NCT03338842?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-01-12. Estimated completion is 2019-11-01.

What conditions does trial NCT03338842 study?

This clinical trial studies the following conditions: Phantom Limb Pain, Lower Limb Amputation Below Knee (Injury), Lower Limb Amputation Above Knee (Injury).

What interventions are being tested in trial NCT03338842?

The interventions under investigation include: Distractor and Lower limb VR (DEVICE).

Who is sponsoring clinical trial NCT03338842?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03338842 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.